Impact of immunosuppressive regimen on ICU acquired pneumonia in critically ill COVID-19.
Sign Up to like & getrecommendations! Published in 2023 at "Minerva anestesiologica"
DOI: 10.23736/s0375-9393.23.17196-3
Abstract: BACKGROUND Immunosuppressors (IS) such as Dexamethasone (DXM), Tocilizumab, and high-dose methylprednisolone boli (HDMB), are used in COVID-19-related acute respiratory distress syndrome (ARDS). This study aimed to determine whether COVID-19 ARDS-related combined IS therapy was associated… read more here.
Keywords: dxm; hdmb; icu acquired; iap ... See more keywords